title: Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil.
authors.affiliation: Department of Internal Medicine (Cancer Research), University of Essen Medical School, West German Cancer Center, Essen, Germany. ralf.hilger@uni-essen.de
authors.forename: R A
authors.initials: RA
authors.lastname: Hilger
authors.forename: H
authors.initials: H
authors.lastname: Richly
authors.forename: M
authors.initials: M
authors.lastname: Grubert
authors.forename: C
authors.initials: C
authors.lastname: Oberhoff
authors.forename: D
authors.initials: D
authors.lastname: Strumberg
authors.forename: M E
authors.initials: ME
authors.lastname: Scheulen
authors.forename: S
authors.initials: S
authors.lastname: Seeber
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D003692:Delayed-Action Preparations; D004317:Doxorubicin / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007262:Infusions, Intravenous; D008081:Liposomes; D009369:Neoplasms / Q000378:metabolism*
chemical_list: D000903:Antibiotics, Antineoplastic; D003692:Delayed-Action Preparations; D008081:Liposomes; D004317:Doxorubicin